Trial Profile
Phase III was intended for hemangioma patients M703101 clinical trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs Propranolol (Primary)
- Indications Haemangioma
- Focus Therapeutic Use
- Sponsors Maruho
- 10 May 2018 Results of retrospective post hoc analysis assessing population pharmacokinetic/ pharmackodynamic modeling (n=32) published in the Journal of Clinical Pharmacology.
- 26 Nov 2015 New trial record